HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Thrombotic Microangiopathies

Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
Also Known As:
Microangiopathies, Thrombotic; Microangiopathy, Thrombotic; Thrombotic Microangiopathy
Networked: 1277 relevant articles (31 outcomes, 46 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Thrombotic Thrombocytopenic Purpura
3. Hemolytic-Uremic Syndrome
4. Nephritis
5. Pulmonary Hypertension (Ayerza Syndrome)

Experts

1. Cooper, David K C: 17 articles (11/2015 - 07/2003)
2. Veyradier, Agnès: 15 articles (11/2014 - 04/2002)
3. Coppo, Paul: 14 articles (09/2015 - 05/2002)
4. Matsumoto, Masanori: 13 articles (10/2015 - 12/2003)
5. Fujimura, Yoshihiro: 13 articles (07/2015 - 12/2003)
6. Frémeaux-Bacchi, Véronique: 13 articles (02/2015 - 11/2007)
7. Jodele, Sonata: 12 articles (11/2015 - 08/2011)
8. Fakhouri, Fadi: 12 articles (02/2015 - 06/2005)
9. George, James N: 10 articles (12/2015 - 01/2004)
10. Davies, Stella M: 10 articles (11/2015 - 08/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Thrombotic Microangiopathies:
1. thymidine 5'-triphosphate (TTP)IBA
2. Complement System Proteins (Complement)IBA
3. von Willebrand FactorIBA
4. eculizumabFDA Link
5. Immunoglobulin G (IgG)IBA
6. Atypical hemolytic uremic syndromeIBA
7. Cyclosporine (Ciclosporin)FDA LinkGeneric
8. gemcitabineFDA Link
9. imatinib (Gleevec)FDA Link
10. AntibodiesIBA

Therapies and Procedures

1. Plasma Exchange
2. Transplants (Transplant)
3. Aftercare (After-Treatment)
4. Transplantation (Transplant Recipients)
5. Homologous Transplantation (Allograft)